Quidel Corporation - Asset Resilience Ratio
Quidel Corporation (QDEL) has an Asset Resilience Ratio of 0.56% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Quidel Corporation PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2025)
This chart shows how Quidel Corporation's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Quidel Corporation to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Quidel Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Quidel Corporation market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $32.40 Million | 0.56% |
| Total Liquid Assets | $32.40 Million | 0.56% |
Asset Resilience Insights
- Limited Liquidity: Quidel Corporation maintains only 0.56% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Quidel Corporation Industry Peers by Asset Resilience Ratio
Compare Quidel Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 6.89% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
Annual Asset Resilience Ratio for Quidel Corporation (2009–2025)
The table below shows the annual Asset Resilience Ratio data for Quidel Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.56% | $32.40 Million | $5.77 Billion | -0.19pp |
| 2024-12-31 | 0.75% | $48.40 Million | $6.42 Billion | +0.19pp |
| 2023-12-31 | 0.57% | $48.40 Million | $8.56 Billion | -0.02pp |
| 2022-12-31 | 0.59% | $52.10 Million | $8.86 Billion | -0.47pp |
| 2021-12-31 | 1.06% | $25.70 Million | $2.43 Billion | -- |
| 2020-12-31 | 0.00% | $0.00 | $1.87 Billion | -- |
| 2017-12-31 | 0.00% | $0.00 | $935.25 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $388.25 Million | -- |
| 2015-12-31 | 0.02% | $63.00K | $406.50 Million | -0.68pp |
| 2014-12-31 | 0.70% | $3.13 Million | $447.41 Million | +0.34pp |
| 2013-12-31 | 0.36% | $969.00K | $271.49 Million | -- |
| 2012-12-31 | 0.00% | $0.00 | $242.10 Million | -- |
| 2011-12-31 | 0.00% | $0.00 | $278.89 Million | -- |
| 2009-12-31 | 2.40% | $4.00 Million | $166.34 Million | -- |
About Quidel Corporation
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laborator… Read more